NCT01638949.
Trial name or title | Multi‐modal Neuroimaging in Alzheimer's Disease (IMAP+) |
Target condition and reference standard(s) | Cognitive decline over three years of follow‐up, reference standard not specified |
Index and comparator tests | 18F‐florbetapir |
Starting date | 2012 |
Contact information | Vincent de La Sayette, University Hospital, Caen |
Notes |